1. Home
  2. BOLT vs GIGM Comparison

BOLT vs GIGM Comparison

Compare BOLT & GIGM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BOLT
  • GIGM
  • Stock Information
  • Founded
  • BOLT 2015
  • GIGM 1998
  • Country
  • BOLT United States
  • GIGM Taiwan
  • Employees
  • BOLT N/A
  • GIGM N/A
  • Industry
  • BOLT Biotechnology: Pharmaceutical Preparations
  • GIGM Computer Software: Programming Data Processing
  • Sector
  • BOLT Health Care
  • GIGM Technology
  • Exchange
  • BOLT Nasdaq
  • GIGM Nasdaq
  • Market Cap
  • BOLT 16.8M
  • GIGM 16.1M
  • IPO Year
  • BOLT 2021
  • GIGM 2000
  • Fundamental
  • Price
  • BOLT $5.50
  • GIGM $1.52
  • Analyst Decision
  • BOLT Buy
  • GIGM
  • Analyst Count
  • BOLT 3
  • GIGM 0
  • Target Price
  • BOLT $50.00
  • GIGM N/A
  • AVG Volume (30 Days)
  • BOLT 16.5K
  • GIGM 8.5K
  • Earning Date
  • BOLT 08-19-2025
  • GIGM 07-31-2025
  • Dividend Yield
  • BOLT N/A
  • GIGM N/A
  • EPS Growth
  • BOLT N/A
  • GIGM N/A
  • EPS
  • BOLT N/A
  • GIGM N/A
  • Revenue
  • BOLT $3,638,000.00
  • GIGM $3,250,000.00
  • Revenue This Year
  • BOLT N/A
  • GIGM N/A
  • Revenue Next Year
  • BOLT $13.62
  • GIGM N/A
  • P/E Ratio
  • BOLT N/A
  • GIGM N/A
  • Revenue Growth
  • BOLT N/A
  • GIGM N/A
  • 52 Week Low
  • BOLT $5.20
  • GIGM $1.30
  • 52 Week High
  • BOLT $14.36
  • GIGM $1.80
  • Technical
  • Relative Strength Index (RSI)
  • BOLT 40.87
  • GIGM 55.57
  • Support Level
  • BOLT $5.30
  • GIGM $1.43
  • Resistance Level
  • BOLT $5.94
  • GIGM $1.58
  • Average True Range (ATR)
  • BOLT 0.31
  • GIGM 0.07
  • MACD
  • BOLT -0.04
  • GIGM 0.01
  • Stochastic Oscillator
  • BOLT 13.34
  • GIGM 55.56

About BOLT Bolt Biotherapeutics Inc.

Bolt Biotherapeutics Inc is a clinical-stage immuno-oncology company. It is developing tumor-targeted therapies that leverage the power of the innate and adaptive immune systems. The company's pipeline candidates are built on our deep expertise in myeloid biology and cancer drug development. The company's proprietary Boltbody ISAC platform technology combines tumor-targeting antibodies with immune-stimulating linker-payloads. The company's pipeline consists of BDC-1001, BDC-3042, and Next-Gen ISAC.

About GIGM GigaMedia Limited

GigaMedia Ltd is a diversified provider of digital entertainment services. Its only segment and principal business is digital entertainment service business, which operates a portfolio of digital entertainment products, targeting digital entertainment service users across Asia. It operates digital entertainment business in Taiwan, Hong Kong and Macau through FunTown.

Share on Social Networks: